In this week’s edition of InnovationRx, we look at the Haitian immigrant who built a $6 billion company treating brain diseases, the drugs RFK Jr. may target after Tylenol, Northwell’s new CEO, and more. To get it in your inbox, subscribe…
In this week’s edition of InnovationRx, we look at the Haitian immigrant who built a $6 billion company treating brain diseases, the drugs RFK Jr. may target after Tylenol, Northwell’s new CEO, and more. To get it in your inbox, subscribe…